AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)

FHS
August 23, 2024
11:18 am

Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel

AstraZeneca announces winners of the 2023 R&D Postdoctoral Challenge

AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge and agreed to fund their postdoctoral positions at one of the Company’s strategic R&D centres in

October 14, 2023

The NIH ices a research project. Is it self-censorship?

Many Americans don’t understand a lot about their health. Whether due to people believing conspiracy theories or simply walking out of their doctor’s offices without

August 7, 2023

Paxlovid didn’t shorten Covid symptoms in vaccinated adults, full trial results confirm

“If it’s Covid, Paxlovid.” That’s how Pfizer markets its Covid-19 antiviral, even as the full results of a study published in the New England Journal

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.